OCC
ORTHOCELL FPO [OCC]
Healthcare · ASX Small Cap
$0.9150 -3.7%
Updated 2026-03-02 · Scores refresh every scan
Appeared in 2 consecutive scans→ Score +0First seen: 2026-02-25
Score Breakdown
Technical50
Catalyst51
Sentiment50
Fundamental83
Momentum42
Risk Gate47
Active Signals
Bullish Signals
- RSI approaching oversold
- Near support level (potential bounce)
- VPT accumulation divergence (bullish)
- Strong cash runway (15 quarters)
- Strong revenue growth (+49%)
- EPS estimates revised upward (+10pts)
- Near 52-week low (11% of range)
- Strong revenue momentum (+49%)
- ASX200 bullish (+1.5% 5d)
- RBA cutting (+2pts)
Risk Signals
- Price below MAs (downtrend)
- Below 200-day MA (long-term downtrend)
- Deeply negative margins (-134%)
- Insufficient sentiment data (defaulting to neutral)
- Neutral/mixed sentiment
- Negative 12-1 momentum (-38%)
Recent Catalysts
NONE Appendix 3Y - Michael McNulty
NONE Appendix 3Y - John Van Der Wielen
NONE Appendix 4D & Half-Year Financial Report
MEDIUM US Market and Operational Update
Recent ASX Announcements
| 2026-02-25 | Appendix 3Y - Michael McNulty |
| 2026-02-25 | Appendix 3Y - John Van Der Wielen |
| 2026-02-23 | Appendix 4D & Half-Year Financial Report PRICE SENSITIVE |
| 2026-02-18 | Orthocell Receives $3.0m R&D Tax Refund PRICE SENSITIVE |
| 2026-02-01 | US Market and Operational Update PRICE SENSITIVE |
Key Metrics
$257.7M
Market Cap
303K
Avg Volume
1.1x
Vol Ratio
$0.85 — $1.70
52-Week Range
0.6%
Short Interest
N/A
Cash Runway
-41.1%
ROE
-133.8%
Profit Margin
CANSLIM Analysis
| Factor | Rating | Detail | |
|---|---|---|---|
| C | Current EPS | fail | EPS Growth: 0% |
| A | Annual Earnings | fail | CAGR: 0% |
| N | New Highs / Catalysts | neutral | |
| S | Supply & Demand | neutral | Float: 84% |
| L | Leader vs Laggard | laggard | RS: -2 |
| I | Institutional Sponsorship | weak | Inst: 2% |
| M | Market Direction | pass | Bullish |
Sector: Healthcare
Ranked #30 of 119 · Sector avg: 51
View all Healthcare signals →